D
한국비티비
219750KOSDAQ의료용 기기 제조업38.0 / 100
Reference Date: 2026-04-13
Financial Score9.5 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Rose 6.6% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
Hanbitbi, established in 1999, is a medical device and biotechnology company that merged with Dongin Biotech in 2024, rebranding as Hanbitbi. Its Medical Device Division produces and sells anti-aging and beauty devices, including home beauty equipment, while the Bio Business Division supplies research reagents and equipment to biotech industries.
Number of Employees
100people
Average Salary
55.7M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 26.524.0Point
PBR
2.44Industry Average 1.702.5Point
Higher than industry avg (caution)
ROE
-14.97Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
54.19Industry Average 10.950.0Point
4.9x industry avg (risky)
Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲511.6% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼137.6% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -177.3% (improving, 3yr)
Detailed News Sentiment
1 totalPositive 0Neutral 0Negative 0
- Neutral
Detailed Momentum
52-week position1.0Point
Near 52w low (13%, downtrend)
Current 906Won52-week high 2,33052-week low 683
1-month return4.0Point
1m +6.59% (slight rise)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
7 totalPositive 0Neutral 7Negative 0
- Neutral주주총회소집결의 (임시주주총회)2026-04-07
- Neutral주주명부폐쇄기간또는기준일설정2026-04-07
- Neutral주식병합결정2026-04-07
- Neutral[기재정정]사업보고서 (2025.12)2026-03-31
- Neutral정기주주총회결과2026-03-26